Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature

BACKGROUND: WHO’s Global Programme to Eliminate Lymphatic Filariasis (LF) uses mass drug administration (MDA) of anthelmintic medications to interrupt LF transmission in endemic areas. Recently, a single dose combination of ivermectin (IVM), diethylcarbamazine (DEC), and albendazole (ALB) was shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Budge, Philip J., Herbert, Carly, Andersen, Britt J., Weil, Gary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973625/
https://www.ncbi.nlm.nih.gov/pubmed/29768412
http://dx.doi.org/10.1371/journal.pntd.0006454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973625/
https://www.ncbi.nlm.nih.gov/pubmed/29768412
http://dx.doi.org/10.1371/journal.pntd.0006454

Ejemplares similares